Sales and Marketing

Showing 15 posts of 11526 posts found.

Teva’s MS treatment disappoints

August 2, 2011 Research and Development, Sales and Marketing Laquinimod, MS, Teva

Teva and Active Biotech’s oral MS drug laquinimod has failed to meet its primary endpoint in a phase III trial. …

Quintiles launches first salesforce in Russia

August 2, 2011 Sales and Marketing CSO, Quintiles, Russia, emerging markets

 Quintiles is set to launch its first contract sales project in Russia with a 40 strong sales team.  The company …

Once daily Viramune set for approval in Europe

August 1, 2011 Sales and Marketing Boehringer Ingelheim, HIV

European regulators have recommended the approval of a new, once-daily form of Boehringer Ingelheim’s HIV treatment Viramune. Viramune (nevirapine) has …
FDA building

FDA refuses to file Eisai’s epilepsy drug

August 1, 2011 Sales and Marketing Eisai, FDA, epilepsy

The FDA has refused to file Eisai’s epilepsy drug perampanel, saying it needs more information for the treatment. The FDA …

Merck KGaA appoints Udit Batra

August 1, 2011 Sales and Marketing appointment, sales and marketing

Udit Batra is to join Merck KGaA as head of its consumer health care division on 1 September. He moves …

Shire sales rocket with 25% growth

July 29, 2011 Sales and Marketing ADHD, Fabry disease, Gaucher's disease, Shire

Specialist pharma company Shire has posted exceptionally strong results for the second quarter, increasing its product sales by 30% and …
Sanofi

Sanofi battles strong headwinds in second quarter

July 29, 2011 Sales and Marketing Sanofi

Sanofi’s acquisition of Genzyme helped its revenue grow in the second quarter, but underlying growth from the French firm disappointed. …

Prescription sales soar in England

July 29, 2011 Sales and Marketing NHS, prescribing

New data shows that prescription sales increased by more than two-thirds in England over the last decade, but a majority …

Sanofi appoints head of strategy

July 28, 2011 Sales and Marketing appointment, sales and marketing

Dr David-Alexandre Gros has joined Sanofi as chief strategy officer with a remit that covers all the group’s business development …
Lilly

Lilly releases details of US doctor payments

July 28, 2011 Medical Communications, Sales and Marketing industry reputation, lilly

Lilly has released details of its payments to doctors and healthcare organisations in the US. The company paid $48.1 million …
Sir John Oldham

A chronic problem for the health service

July 27, 2011 Sales and Marketing NHS, long term conditions

Sir John Oldham is not widely known outside the Department of Health, but he might just have the most difficult …
GlaxoSmithKline

GSK sales down on Avandia and pandemic products

July 27, 2011 Research and Development, Sales and Marketing GSK

GlaxoSmithKline has posted a slide in revenue for the second quarter, but is buoyed by strong underlying growth. Sales were …
Janssen's Velcade (bortezomib)

NICE recommends thalidomide ahead of Velcade

July 27, 2011 Sales and Marketing NICE, Thalidomide, Velcade

NICE has recommended Celgene’s thalidomide ahead of J&J’s Velcade for multiple myeloma. Celgene’s drug is recommended in combination with an …
Augmentin tablets

Augmentin recall expanded on contamination fears

July 26, 2011 Manufacturing and Production, Sales and Marketing Augmentin, GSK, recalls

GlaxoSmithKline has been drawn further into concerns about contamination of pharmaceuticals, foods and beverages with plasticiser compounds, after authorities in …

NICE consults on asthma drug reducing procedure

July 26, 2011 Sales and Marketing NICE, asthma

NICE has launched a consultation in the UK on a new medical procedure which, if it proves safe and effective, …
The Gateway to Local Adoption Series

Latest content